CompletedNot applicableNCT00916487

Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption

Studying Disorder of fructose metabolism

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sciotec Diagnostic Technologies GmbH
Principal Investigator: Peter Komericki, MD
Medical University of Graz
Intervention: Fructosin(dietary_supplement)
Enrollment: 65 enrolled
Eligibility: 18-80 years · All sexes
Timeline: 2009 – 2010

Study locations (1)

Medical University of Graz, Graz, Styria, Austria

Collaborators

Austrian Research Promotion Agency

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00916487 on ClinicalTrials.gov

← Back to all trials